Nanobiotix S.A. (NBTX)
NASDAQ: NBTX · Real-Time Price · USD
25.75
-2.15 (-7.71%)
At close: Oct 2, 2026, 4:00 PM EDT
26.22
+0.47 (1.83%)
After-hours: Oct 2, 2026, 7:32 PM EDT

Nanobiotix Revenue

Nanobiotix had revenue of 5.55M EUR in the half year ending June 30, 2026, a decrease of -40.24%. This brings the company's revenue in the last twelve months to 11.51M, up 13.26% year-over-year. In the year 2025, Nanobiotix had annual revenue of 32.59M.

Revenue (ttm)
11.51M EUR
Revenue Growth
+13.26%
P/S Ratio
99.45
Revenue / Employee
115,060 EUR
Employees
100
Market Cap
1.31B USD

Revenue Chart

* This company reports financials in EUR.

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202532.59M39.78M-
Dec 31, 2024-7.19M-43.40M-
Dec 31, 202336.21M31.43M658.12%
Dec 31, 20224.78M2.13M80.43%
Dec 31, 20212.65M135.00K5.37%
Dec 31, 20202.51M-29.00K-1.14%
Dec 31, 20192.54M-938.00K-26.96%
Dec 31, 20183.48M-242.53K-6.52%
Dec 31, 20173.72M-1.70M-31.36%
Dec 31, 20165.42M1.41M35.03%
Dec 31, 20154.02M1.24M44.91%
Dec 31, 20142.77M2.59M1,398.23%
Dec 31, 2013184.94K-785.67K-80.95%
Dec 31, 2012970.61K-389.71K-28.65%
Dec 31, 20111.36M225.46K19.87%
Dec 31, 20101.13M-1.63M-59.00%
Dec 31, 20092.77M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.